2024 INTERIM REPORT
Brokers Suggest Investing in JD.com (JD): Read This Before Placing a Bet
Hong Kong stocks soared across the board! The Hang Seng Index rose nearly 3%, while the A50 made a sharp surge. What happened?
What exactly happened? Analysts believe that there are three main driving factors.
Express News | China National Pharmaceutical Group Taiji and jd health signed a strategic cooperation agreement.
JD Health (06618.HK): Impressive performance on the profit end, high-quality and steady growth.
Key Points: Event: JD Health releases its mid-term performance for 2024. In the first half of 2024, the company achieved a revenue of 28.344 billion yuan, a year-on-year growth of 4.6%. Among them, the sales of pharmaceutical and health products business (pharmaceutical e-commerce)
jd health (06618): According to the first public offering of shares reward plan, 1 million new shares will be issued.
JD Health (06618) announced in a statement that, according to the first public sale of shares adopted on November 23, 2020...